Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 1, 2019Vancomycin 1000 mg in NS 250 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1235-2019Class IITerminatedMay 1, 2019Sodium Citrate 4%Lack of sterility assurance.CMC Enterprise Pharmacy · D-1234-2019Class IITerminatedMay 1, 2019Sodium Bicarbonate 150 mEq in D5W 1000 mL bagsLack of sterility assurance.CMC Enterprise Pharmacy · D-1233-2019Class IITerminatedMay 1, 2019Phenylephrine 40 mg in 0.9% Sodium Chloride 250 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1232-2019Class IITerminatedMay 1, 2019Phenylephrine 20 mg NS 250 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1231-2019Class IITerminatedMay 1, 2019Phenylephrine 0.8 mg/10 mL NSLack of sterility assurance.CMC Enterprise Pharmacy · D-1230-2019Class IITerminatedMay 1, 2019Heparin Pork 30Lack of sterility assurance.CMC Enterprise Pharmacy · D-1229-2019Class IITerminatedMay 1, 2019Chlorothiazide 100 mgLack of sterility assurance.CMC Enterprise Pharmacy · D-1228-2019Class IITerminatedMay 1, 2019CefTRIAXone 1 GMLack of sterility assurance.CMC Enterprise Pharmacy · D-1227-2019Class IITerminatedMay 1, 2019CeFAZolin 3 gm 100 mg/mLLack of sterility assurance.CMC Enterprise Pharmacy · D-1226-2019Class IITerminatedMay 1, 2019CeFAZolin 2 GM a) in NS 100 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1225-2019Class IITerminatedMay 1, 2019CeFAZolin 1 GM a) in NS 100 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1224-2019Class IITerminatedMay 1, 2019Lidocaine 1% - Sodium Bicarbonate 8.4% 1:1Lack of sterility assurance.CMC Enterprise Pharmacy · D-1223-2019Class IITerminatedMay 1, 2019Lidocaine 1% - Sodium Bicarb 8.4% 10:1Lack of sterility assurance.CMC Enterprise Pharmacy · D-1222-2019Class IITerminatedMay 1, 2019Lidocaine Buffered with J-Tip 0.25 mLLack of sterility assurance.CMC Enterprise Pharmacy · D-1221-2019Class IITerminatedMay 1, 2019Alteplase 1 mg/mL 1 mL in 10 mL syringeLack of sterility assurance.CMC Enterprise Pharmacy · D-1220-2019Class IITerminatedMay 1, 2019Oxytocin 30 units in NS 500 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1219-2019Class IITerminatedMay 1, 2019Norepinephrine 16 mg in NS 250 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1218-2019Class IITerminatedMay 1, 2019NICARdipine 25 mg in NS 250 mL EXCEL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1217-2019Class IITerminatedMay 1, 2019Magnesium Sulfate 6 GM in NS 50 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1216-2019Class IITerminatedMay 1, 2019Magnesium Sulfate 4 GM in NS 50 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1215-2019Class IITerminatedMay 1, 2019Magnesium Sulfate 2 GM in NS 50 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1214-2019Class IITerminatedMay 1, 2019Magnesium Sulfate 1 GM in NS 50 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1213-2019Class IITerminatedMay 1, 2019Labetalol 20 mg/4 mLLack of sterility assurance.CMC Enterprise Pharmacy · D-1212-2019Class IITerminatedMay 1, 2019Diltiazem 250 mg in NS 250 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1211-2019Class IITerminatedMay 1, 2019Clindamycin 900 mg in NS 50 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1210-2019Class IITerminatedMay 1, 2019Dexmedetomidine 400 mcg in NS 100 mL bagLack of sterility assurance.CMC Enterprise Pharmacy · D-1209-2019Class IIITerminatedApr 24, 2019Remifentanil HCl active pharmaceutical ingredientFailed Impurities/Degradation Specifications: Unknown impurity above specification limits.Johnson Matthey Inc. · D-1252-2019Class ITerminatedApr 24, 2019Kopi Jantan Tradisional Natural Herbs CoffeeMarketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared sildenafil and tadalafil, two FDA approved drugs for the treatment...Brian P. Richardson · D-1206-2019Class IITerminatedApr 24, 2019Amoxicillin for Oral Suspension USPSubpotent Product: assay results for Amoxicillin were below the specification limits.Teva Pharmaceuticals USA · D-1205-2019Class IITerminatedApr 24, 2019Prostaglandin Tri-Mix 30:30:1 InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1204-2019Class IITerminatedApr 24, 2019Prostaglandin Tri-Mix 20:25:1 InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1203-2019Class IITerminatedApr 24, 2019Prostaglandin Tri-Mix 8.33:22.5:0.833 InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1202-2019Class IITerminatedApr 24, 2019Prostaglandin Tri-Mix 2.5:7.5:0.25 InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1201-2019Class IITerminatedApr 24, 2019Prostaglandin Tri-Mix 5:15:0.5 InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1200-2019Class IITerminatedApr 24, 2019Phenol 10% InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1199-2019Class IITerminatedApr 24, 2019Papaverine 30 mg/mL InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1198-2019Class IITerminatedApr 24, 2019Papaverine 30 mg/Phentolamine 0.5 mg/mLLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1197-2019Class IITerminatedApr 24, 2019HCG 11,00Units/B 12 11Lack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1196-2019Class IITerminatedApr 24, 2019Estrone 5mg/mL Oil InjectionLack of sterility assurance.Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy · D-1195-2019